| Ozi bụ isi | |
| Aha ngwaahịa | Amantanamine hydrochloride (ọkwa ọgwụ) |
| CAS Mba. | 665-66-7 |
| Ọdịdị | White Fine Crystal ntụ ntụ |
| Ọkwa | Ọkwa Pharma |
| Mmiri Solubility | Soluble |
| Nchekwa | Chekwaa n'okpuru +30 Celsius. |
| Ndụ shelf | afọ 2 |
| ngwugwu | 25kg/Drum |
Nkọwa ngwaahịa
| Aha ngwaahịa: | Amantanamine hydrochloride |
| Ụdị okwu: | Amantanamine hydrochloride, 1-Adamantylamine hydrochloride, 1-Aminoadamantane hydrochloride; Hydrochloride (200 mg); 1-AdaMantanaMine hydrochloride, 99+% 100GR;1-AdaMantanaMine hydrochloride, 99+% 25GR;1-AdaMantanaMine hydrochloride,99+% 5GR;1-adamantane amine hydrochloride;1-Adamantanamine Hydrochloride; Hydrochloride |
| CAS: | 665-66-7 |
| MF: | C10H18ClN |
| MW: | 187.71 |
| EINECS: | 211-560-2 |
| Ụdị ngwaahịa: | Nje Virus influenza;API;Intermediates & Fine Chemicals;Dopamine receptors;SYMADINE;inhibitor;Adamantane dravatives;chiral;Adamantanes;Pharmaceuticals;API's;1;665-66-7 |
Iji ụlọ ọgwụ
Amantanamine hydrochlorideA na-eji ya na ọgwụgwọ prophylactic ma ọ bụ symptomatic nke influenza A.
A na-ejikwa ya dị ka onye nnọchi anya antiparkinsonian, na-agwọ mmeghachi omume pyramidal ọzọ, yana maka neuralgia postherpetic.
A na-ejikwa ya NMDA-receptor antagoinst.






